此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

The Impact of Social Proximity on Conversion to Generic Prescription Medications

2012年5月16日 更新者:National Bureau of Economic Research, Inc.
The goal of this project is to understand the effects of receiving peer information on individuals' conversion rates from brand name prescription medication to generic prescription medication.

研究概览

详细说明

At companies where employees are predominantly union members, we will compare the efficacy of a peer information intervention using a testimonial from a union identified employee to an intervention using a testimonial with no union identification, as well as to a no-testimonial intervention.

The control arm will receive a letter signed by our partner company's Chief Medical Officer, explaining the health and monetary benefits of switching from brand name prescription medication to generic prescription medication. The testimonial treatment arm will receive the exact same letter, but the letter will feature an employee's testimonial along with the first name, last initial, city and state of the employee giving the testimonial. The testimonial and union arm will receive the same letter as the testimonial treatment arm but with the addition of the union affiliation of the employee giving the testimonial.

研究类型

介入性

注册 (实际的)

10000

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Missouri
      • St. Louis、Missouri、美国、63121
        • Express Scripts

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Employee of a company that uses Express Scripts as its pharmacy benefits manager.
  • Employee at a company with predominantly union employees.
  • Currently taking a brand name medication with an exact generic equivalent.

Exclusion Criteria:

  • Employees on any psychological prescription medication.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Testimonial and Union Arm
The testimonial and union arm will receive the same letter as the testimonial treatment arm but with the addition of the union affiliation of the employee giving the testimonial.
At companies where employees are predominantly union members, we will compare the efficacy of a peer information intervention using a testimonial from a union identified employee to an intervention using a testimonial with no union identification, as well as to a no-testimonial intervention.
实验性的:Control
The control arm will receive a letter signed by our partner company's Chief Medical Officer, explaining the health and monetary benefits of switching from brand name prescription medication to generic prescription medication.
At companies where employees are predominantly union members, we will compare the efficacy of a peer information intervention using a testimonial from a union identified employee to an intervention using a testimonial with no union identification, as well as to a no-testimonial intervention.
实验性的:Testimonial Treatment Arm
The testimonial treatment arm will receive the exact same letter as the control arm, but the letter will feature an employee's testimonial along with the first name, last initial, city and state of the employee giving the testimonial.
At companies where employees are predominantly union members, we will compare the efficacy of a peer information intervention using a testimonial from a union identified employee to an intervention using a testimonial with no union identification, as well as to a no-testimonial intervention.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Conversion from Brand Name to Generic Prescription Medication
大体时间:One month to one year after the intervention.
We will measure conversion rates of employees from brand name to generic prescription medication by treatment arm.
One month to one year after the intervention.

次要结果测量

结果测量
措施说明
大体时间
Union Status and Conversation to Generic Medication
大体时间:One month to one year after the intervention.
We will see how union affiliation affects the employee conversion rates from brand name to prescription medication by treatment arm.
One month to one year after the intervention.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:David Laibson, Ph.D、National Bureau of Economic Research

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2011年3月1日

初级完成 (实际的)

2012年5月1日

研究完成 (实际的)

2012年5月1日

研究注册日期

首次提交

2010年11月30日

首先提交符合 QC 标准的

2010年11月30日

首次发布 (估计)

2010年12月1日

研究记录更新

最后更新发布 (估计)

2012年5月18日

上次提交的符合 QC 标准的更新

2012年5月16日

最后验证

2012年5月1日

更多信息

与本研究相关的术语

其他研究编号

  • 0002
  • P30AG034532 (美国 NIH 拨款/合同)

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅